Caris Life Sciences, Inc. · NASDAQ:CAI
Spetzler David Baxley sold 597,212 Caris Life Sciences, Inc. shares (Form 4)
Traded Sep 3 to Sep 4, 2026 · Filed Sep 4, 2026
From Sep 3 to Sep 4, 2026, Spetzler David Baxley (President) sold 597,212 Caris Life Sciences, Inc. shares at an average US$24.84 for US$14.8M, leaving 1,182,871 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 597,212 shares
- Price
- US$24.84 average (US$24.76 to US$25.32)
- Value
- US$14.8M
- Holding after
- 1,182,871 shares
- Trading plan
- No
- Role
- President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | Option exercise | 1,000,000 | US$2.44 | 1,530,083 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 393,100 | US$24.76 | 1,136,983 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 84,900 | US$25.32 | 1,052,083 | Direct |
| Sep 4, 2026 | Common Stock | Option exercise | 250,000 | US$2.44 | 1,302,083 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 119,212 | US$24.76 | 1,182,871 | Direct |
Source
Related
- Caris Life Sciences, Inc.
- Spetzler David Baxley
- Caris Life Sciences, Inc. shareholders
- Form 4 · Spetzler David Baxley · May 18, 2026
- Form 4 · Denton John Russel · Sep 23, 2026
- Form 4 · Brille Brian J · Sep 17, 2026
- Form 4 · Castleman Peter M · Aug 14, 2026
- Form 4 · Phillips T Danny · Aug 14, 2026
- Form 4 · Minor Lloyd · Aug 14, 2026